DR. MATHEW JOHN JOSEPH M.D. NPI 1922280692

NPI Information

  • NPI: 1922280692
  • Provider Name: DR. MATHEW JOHN JOSEPH, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 103 NATCHEZ PARK DR STE 103
    DICKSON, TN
    ZIP 37055
  • Phone: (615) 740-7025

Map and Directions

Get Directions

NPI Details

DR. Mathew John Joseph, M.D. is a hematology and oncology internal medicine in Dickson, TN with 24 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Mathew John Joseph, M.D. NPI is 1922280692. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:2002

The provider's business location address is:

103 NATCHEZ PARK DR STE 103
DICKSON, TN
ZIP 37055-013
Phone: (615) 740-7025
Fax: (615) 740-9508

The NPI 1922280692 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Protein measurement, serum (HCPCS:84165)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Folic acid level, serum (HCPCS:82746)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Automated urinalysis test (HCPCS:81003)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Stool analysis for blood, by peroxidase activity (HCPCS:82272)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Uric acid level, blood (HCPCS:84550)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Red blood count, automated test (HCPCS:85045)
  • Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth (HCPCS:G0408)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)

The enumeration date for this NPI number is 12/4/2007 and was last updated on 11/6/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology43461TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11505837MEDICAIDTENNESSEE
24183143OTHERTENNESSEEBCBS OF TN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.